A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

This study suggests that immunotherapy may not be the optimal ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 — A team of doctors and researchers have identified a new ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

This paper explores the potential of mitochondrial-associated programmed-cell-death (mtPCD) patterns as biomarkers for ...

A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

13, 2025 — A discovery about how severe COVID-19 damages lung cells suggests that an existing ... microscopic particles emitted from certain types of commonly fitted brake pads can be more ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

Across NSCLC and small cell lung cancer (SCLC), data from the ... Improvements in survival rates are notable in both types of lung cancer, but mostly in NSCLC. Absolute improvements in lung ...

A new discovery from Rutgers Health scientists could lead to better treatments for a deadly lung disease called Idiopathic ...